| Primary |
| Product Used For Unknown Indication |
40.7% |
| Rheumatoid Arthritis |
11.1% |
| Osteoarthritis |
7.4% |
| Back Pain |
5.6% |
| Arthralgia |
3.7% |
| Arthritis |
3.7% |
| Drug Use For Unknown Indication |
3.7% |
| Costochondritis |
1.9% |
| Cramp |
1.9% |
| Epicondylitis |
1.9% |
| Gout |
1.9% |
| Hypertension |
1.9% |
| Intervertebral Disc Protrusion |
1.9% |
| Joint Pain |
1.9% |
| Joint Swelling |
1.9% |
| Lateral Epicondylitis |
1.9% |
| Migraine |
1.9% |
| Myalgia |
1.9% |
| Pain |
1.9% |
| Prophylaxis |
1.9% |
|
| Contusion |
8.7% |
| Epistaxis |
8.7% |
| Toxicity To Various Agents |
8.7% |
| Angina Pectoris |
4.3% |
| Epilepsy |
4.3% |
| Gastric Haemorrhage |
4.3% |
| Gastric Ulcer |
4.3% |
| Gastrointestinal Haemorrhage |
4.3% |
| Grand Mal Convulsion |
4.3% |
| Haemoglobin Decreased |
4.3% |
| Hallucination |
4.3% |
| Hypersensitivity |
4.3% |
| Insomnia |
4.3% |
| International Normalised Ratio Increased |
4.3% |
| Lip Swelling |
4.3% |
| Lymphadenopathy |
4.3% |
| Movement Disorder |
4.3% |
| Oesophageal Haemorrhage |
4.3% |
| Product Quality Issue |
4.3% |
| Rash Maculo-papular |
4.3% |
|
| Secondary |
| Product Used For Unknown Indication |
45.0% |
| Drug Use For Unknown Indication |
10.0% |
| Rheumatoid Arthritis |
10.0% |
| Suicide Attempt |
8.8% |
| Prostatitis |
6.3% |
| Bursitis |
3.8% |
| Myelodysplastic Syndrome |
2.5% |
| Neuralgia |
2.5% |
| Drug Use Fo Runknown Indication |
1.3% |
| Prostatitis |
1.3% |
| Anxiety |
1.3% |
| Fracture Pain |
1.3% |
| Migraine |
1.3% |
| Multiple Sclerosis |
1.3% |
| Musculoskeletal Chest Pain |
1.3% |
| Sciatic Nerve Injury |
1.3% |
| Wheezing |
1.3% |
|
| Toxicity To Various Agents |
13.0% |
| Renal Failure Acute |
8.7% |
| Tremor |
8.7% |
| Vision Blurred |
8.7% |
| Gastric Ulcer |
4.3% |
| Increased Tendency To Bruise |
4.3% |
| Malaise |
4.3% |
| Musculoskeletal Chest Pain |
4.3% |
| Overdose |
4.3% |
| Pancytopenia |
4.3% |
| Renal Impairment |
4.3% |
| Respiratory Arrest |
4.3% |
| Suicidal Ideation |
4.3% |
| Thrombocytopenia |
4.3% |
| Torticollis |
4.3% |
| Urinary Retention |
4.3% |
| Urticaria |
4.3% |
| Weight Decreased |
4.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.2% |
| Osteoporosis |
21.4% |
| Multiple Sclerosis |
14.6% |
| Depression |
7.8% |
| Immunodeficiency Common Variable |
4.9% |
| Plasma Cell Myeloma |
4.9% |
| Back Pain |
2.9% |
| Migraine |
2.9% |
| Relapsing-remitting Multiple Sclerosis |
2.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Angioedema |
1.0% |
| Breast Cancer |
1.0% |
| Cellulitis |
1.0% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
1.0% |
| Chronic Myeloid Leukaemia |
1.0% |
| Constipation |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Gout |
1.0% |
| Headache |
1.0% |
| Hepatitis C |
1.0% |
|
| Weight Decreased |
11.1% |
| Visual Impairment |
8.9% |
| Glossitis |
6.7% |
| Pericardial Effusion |
6.7% |
| Transaminases Increased |
6.7% |
| Urinary Tract Infection |
6.7% |
| Decreased Appetite |
4.4% |
| Headache |
4.4% |
| Pulmonary Embolism |
4.4% |
| Somnolence |
4.4% |
| Staphylococcal Infection |
4.4% |
| Stress Fracture |
4.4% |
| Thirst |
4.4% |
| Toxicity To Various Agents |
4.4% |
| Vomiting |
4.4% |
| Wheezing |
4.4% |
| Acne |
2.2% |
| Atrioventricular Block Complete |
2.2% |
| Atypical Fracture |
2.2% |
| Breast Mass |
2.2% |
|
